{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-004502","form_type":"8-K","ticker":"SIGY","cik":"0001642159","company_name":"Sigyn Therapeutics, Inc.","filed_at":"2024-01-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.950701+00:00","generated_at":"2026-06-06T13:41:45.594949+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Sigyn Therapeutics effects 1-for-40 reverse stock split; symbol gets 'D' suffix for 20 days","bullets":["Reverse stock split effective January 30, 2024 at a 1-for-40 ratio.","Ticker symbol changes to 'SIGYD' for 20 business days per FINRA rules.","Standard symbol 'SIGY' will resume after the 20-business-day period.","No change in the company's CUSIP or par value was disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-004502","json":"https://secwatch.observer/filing/0001493152-24-004502.json","markdown":"https://secwatch.observer/filing/0001493152-24-004502.md","text":"https://secwatch.observer/filing/0001493152-24-004502.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642159/000149315224004502/0001493152-24-004502-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642159/000149315224004502/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T13:41:45.594949+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}